These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8005855

  • 1. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs.
    Kilbourn RG, Owen-Schaub LB, Cromeens DM, Gross SS, Flaherty MJ, Santee SM, Alak AM, Griffith OW.
    J Appl Physiol (1985); 1994 Mar; 76(3):1130-7. PubMed ID: 8005855
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG, Gross SS, Lodato RF, Adams J, Levi R, Miller LL, Lachman LB, Griffith OW.
    J Natl Cancer Inst; 1992 Jul 01; 84(13):1008-16. PubMed ID: 1376778
    [Abstract] [Full Text] [Related]

  • 3. Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.
    Kilbourn RG, Fonseca GA, Trissel LA, Griffith OW.
    Cancer J Sci Am; 2000 Feb 01; 6 Suppl 1():S21-30. PubMed ID: 10685654
    [Abstract] [Full Text] [Related]

  • 4. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.
    Kilbourn RG, Fonseca GA, Griffith OW, Ewer M, Price K, Striegel A, Jones E, Logothetis CJ.
    Crit Care Med; 1995 Jun 01; 23(6):1018-24. PubMed ID: 7774211
    [Abstract] [Full Text] [Related]

  • 5. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs.
    Kilbourn RG, Cromeens DM, Chelly FD, Griffith OW.
    Crit Care Med; 1994 Nov 01; 22(11):1835-40. PubMed ID: 7956289
    [Abstract] [Full Text] [Related]

  • 6. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
    Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF.
    Proc Natl Acad Sci U S A; 1990 May 01; 87(9):3629-32. PubMed ID: 2333306
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide inhibition attenuates systemic hypotension produced by protamine.
    Raikar GV, Hisamochi K, Raikar BL, Schaff HV.
    J Thorac Cardiovasc Surg; 1996 Jun 01; 111(6):1240-6; discussion 1246-7. PubMed ID: 8642826
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular actions of NG-methyl-L-arginine are abolished in a canine shock model using high-dose endotoxin.
    Klabunde RE, Helgren MC.
    Res Commun Chem Pathol Pharmacol; 1992 Oct 01; 78(1):57-68. PubMed ID: 1462049
    [Abstract] [Full Text] [Related]

  • 9. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis.
    Kilbourn RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF.
    Biochem Biophys Res Commun; 1990 Nov 15; 172(3):1132-8. PubMed ID: 2244897
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of NG-methyl-L-arginine in chronically instrumented conscious dogs.
    Lechevalier T, Doursout MF, Chelly JE, Kilbourn RG.
    J Appl Physiol (1985); 1994 Jul 15; 77(1):471-5. PubMed ID: 7525530
    [Abstract] [Full Text] [Related]

  • 11. NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock.
    Klabunde RE, Ritger RC.
    Biochem Biophys Res Commun; 1991 Aug 15; 178(3):1135-40. PubMed ID: 1872835
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of NG-monomethyl-L-arginine against hypotension inducted by combined tumour necrosis factor-alpha and whole body hyperthermia in rats.
    Makino M, Lodato RF, Stephens LC, Strebel FR, Jenkins G, Ohno S, Sakaguchi Y, Kostergaard J, Tomasovic SP, Bull JM.
    Int J Hyperthermia; 1996 Aug 15; 12(5):617-34. PubMed ID: 8886889
    [Abstract] [Full Text] [Related]

  • 13. NG-methyl-L-arginine restores arterial pressure in hemorrhaged rats.
    Klabunde RE, Slayton KJ, Ritger RC.
    Circ Shock; 1993 May 15; 40(1):47-52. PubMed ID: 8324889
    [Abstract] [Full Text] [Related]

  • 14. Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice.
    Orucevic A, Lala PK.
    Cancer Immunol Immunother; 1996 Jan 15; 42(1):38-46. PubMed ID: 8625365
    [Abstract] [Full Text] [Related]

  • 15. Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice.
    Kondapaneni M, McGregor JR, Salvemini D, Laubach VE, Samlowski WE.
    J Immunother; 2008 May 15; 31(4):325-33. PubMed ID: 18391763
    [Abstract] [Full Text] [Related]

  • 16. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
    Mohaupt M, Schoecklmann HO, Schulze-Lohoff E, Sterzel RB.
    J Hypertens; 1994 Apr 15; 12(4):401-8. PubMed ID: 8064164
    [Abstract] [Full Text] [Related]

  • 17. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
    Orucevic A, Lala PK.
    Cell Immunol; 1996 Apr 10; 169(1):125-32. PubMed ID: 8612285
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice.
    Samlowski WE, Yim CY, McGregor JR, Kwon OD, Gonzales S, Hibbs JB.
    J Immunother Emphasis Tumor Immunol; 1995 Oct 10; 18(3):166-78. PubMed ID: 8770772
    [Abstract] [Full Text] [Related]

  • 19. Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.
    Joly GA, Ayres M, Chelly F, Kilbourn RG.
    Biochem Biophys Res Commun; 1994 Feb 28; 199(1):147-54. PubMed ID: 7510104
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor.
    Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB, Samlowski WE.
    J Immunol; 1995 Nov 01; 155(9):4382-90. PubMed ID: 7594598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.